Related Experiment Video
Updated: Apr 15, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Epidemic history of major genotypes of hepatitis C virus in Uruguay
M Castells1, G Bello2, S Ifrán3
1Laboratorio de Virología Molecular, Regional Norte, Centro Universitario de la Regional Noroeste, Universidad de la República, Rivera 1350, Salto, Uruguay.
Insights
Hepatitis C virus (HCV) subtypes 1a, 1b, and 3a fuel Uruguay's epidemic, driven by multiple introductions and local strains. This study reveals the molecular epidemiology and evolutionary history of HCV in Uruguay for the first time.
Area of Science:
- * Virology
- * Epidemiology
- * Molecular Biology
Background:
- * Hepatitis C virus (HCV) infects over 170 million globally, causing significant liver disease mortality.
- * HCV genotypes and subtypes, particularly 1a, 1b, and 3a, are key drivers of epidemics worldwide.
- * Limited data exists on HCV epidemiology and evolutionary history in Uruguay.
Purpose of the Study:
- * To investigate the molecular epidemiology of HCV in Uruguay.
- * To determine the evolutionary and demographic history of circulating HCV strains.
- * To identify the major HCV genotypes and subtypes prevalent in the Uruguayan population.
Main Methods:
- * Analysis of 153 Hepatitis C virus NS5B gene sequences from Uruguayan patients (2005-2011).
- * Phylogenetic analysis to determine HCV subtype distribution and identify local clades.
- * Molecular clock modeling to reconstruct evolutionary and demographic history.
Main Results:
- * Subtypes 1a (56%), 3a (26%), and 1b (18%) were the predominant HCV strains identified in Uruguay.
- * Subtype 1a sequences were further classified into two distinct clades.
- * Four novel local HCV clades (UY-1a(I), UY-1a(II), UY-1a(III), and UY-3a) were identified, comprising 39% of analyzed viruses.
- * The major Uruguayan clade UY-1a(I) showed an epidemic history of rapid expansion followed by a growth rate reduction since 2000-2005.
Conclusions:
- * HCV epidemic in Uruguay is characterized by multiple introductions of subtypes 1a, 1b, and 3a, alongside local dissemination of specific strains.
- * This study provides the first comprehensive insight into the molecular epidemiology and epidemic history of HCV in Uruguay.
- * Findings highlight the importance of understanding local HCV dynamics for effective public health strategies.
Abstract:
Worldwide, more than 170 million people are chronically infected with the hepatitis C virus (HCV) and every year die more than 350,000 people from HCV-related liver diseases. Recently, HCV was reclassified into seven major genotypes and 67 subtypes. Some subtypes as 1a, 1b and 3a, have become epidemic as a result of the new parenteral transmission routes and are responsible for most HCV infections in Western countries. HCV 1a subtype have been sub-categorized into two separate sub clades. Recent studies based on the analysis of NS5B genome region, reveal that HCV epidemics in Argentina and Brazil are characterized by multiple introductions events of subtypes 1a, 1b and 3a, followed by subsequent local dispersion. There is no data about HCV genotypes circulating in Uruguay and their evolutionary and demographic history. To this end, a total of 153 HCV NS5B gene sequences were obtained from Uruguayan patients between 2005 and 2011. 86 (56%) sequences grouped with subtype 1a, 40 (26%) with subtype 3a and 27 (18%) with subtype 1b. Furthermore, subtype 1a sequences were distributed among both clades, 1 (n=62, 72%) and 2 (n=24, 28%). Four local HCV clades were found: UY-1a(I), UY-1a(II), UY-1a(III) and UY-3a; comprising a 39% of all HCV viruses analyzed in this study. HCV epidemic in Uruguay has been driving by multiple introductions of subtypes 1a, 1b and 3a and by local dissemination of a few country-specific strains. The evolutionary and demographic history of the major Uruguayan HCV clade UY-1a(I) was reconstructed under two different molecular clock rate models and displayed an epidemic history characterized by an initial phase of rapid expansion followed by a more recent reduction of growth rate since 2000-2005. This is the first comprehensive study about the molecular epidemiology and epidemic history of HCV in Uruguay.
Related Concept Videos
Hepatitis
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Retroviruses
Cytomegalovirus Disease

